Literature DB >> 9515675

Multivariate model for predicting relapse in human brucellosis.

J Solera1, E Martínez-Alfaro, A Espinosa, M L Castillejos, P Geijo, M Rodríguez-Zapata.   

Abstract

Demographic, clinical, and laboratory data from 200 consecutive patients with acute brucellosis were analysed with univariate and multivariate methods to identify correlates of relapse. A risk score for predicting relapse was then calculated by using Cox proportional hazard model. The independent predictors of relapse were temperature of 38.3 degrees C or higher, positive blood cultures at baseline, and the duration of symptoms before treatment <10 days. Stratification according to the risk score demonstrated that rates of relapse were significantly different between risk groups (P<0.0001). The low-risk group had a 4.5% probability (6 of 135) of relapse at 12 months. In contrast, relapse was present in 15 of 47 patients in the medium-risk group (P<0.0017); and in 12 of 18 patients in the high-risk group (P<0.0001). This study provides a rational basis for estimating the risk of relapse in patients with acute brucellosis, and may be helpful in deciding what subjects might benefit from extra attention.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515675     DOI: 10.1016/s0163-4453(98)93342-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  20 in total

1.  Posttreatment follow-Up of brucellosis by PCR assay.

Authors:  P Morata; M I Queipo-Ortuño; J M Reguera; M A García-Ordoñez; C Pichardo; J D Colmenero
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Bacteremic and nonbacteremic brucellosis: clinical and laboratory observations.

Authors:  A Kadanali; K Ozden; U Altoparlak; A Erturk; M Parlak
Journal:  Infection       Date:  2009-01-12       Impact factor: 3.553

Review 3.  Review of brucellosis cases from laboratory exposures in the United States in 2008 to 2011 and improved strategies for disease prevention.

Authors:  R M Traxler; M A Guerra; M G Morrow; T Haupt; J Morrison; J R Saah; C G Smith; C Williams; A T Fleischauer; P A Lee; D Stanek; I Trevino-Garrison; P Franklin; P Oakes; S Hand; S V Shadomy; D D Blaney; M W Lehman; T J Benoit; R A Stoddard; R V Tiller; B K De; W Bower; T L Smith
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

4.  Treatment of brucellosis: a systematic review of studies in recent twenty years.

Authors:  Seyed Mohammad Alavi; Leila Alavi
Journal:  Caspian J Intern Med       Date:  2013

5.  Acute prostatitis as an uncommon presentation of brucellosis.

Authors:  Elif Hakko; Melda Ozdamar; Salih Turkoglu; Semra Calangu
Journal:  BMJ Case Rep       Date:  2009-05-25

Review 6.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

7.  Dissecting aneurysm of the thoracic aorta in a patient with nephrotic syndrome and brucellosis.

Authors:  M Kusztal; A Dorobisz; J Kuzniar; J Garcarek; K Koscielska-Kasprzak; D Kaminska; T Porazko; M Klinger
Journal:  Int Urol Nephrol       Date:  2007-02-21       Impact factor: 2.370

8.  Brucella melitensis invades murine erythrocytes during infection.

Authors:  Marie-Alice Vitry; Delphine Hanot Mambres; Michaël Deghelt; Katrin Hack; Arnaud Machelart; Frédéric Lhomme; Jean-Marie Vanderwinden; Marjorie Vermeersch; Carl De Trez; David Pérez-Morga; Jean-Jacques Letesson; Eric Muraille
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

9.  Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever.

Authors:  J Njeru; K Henning; M W Pletz; R Heller; C Forstner; S Kariuki; E M Fèvre; H Neubauer
Journal:  BMC Infect Dis       Date:  2016-06-03       Impact factor: 3.090

10.  Rapid diagnosis of human brucellosis by quantitative real-time PCR: a case report of brucellar spondylitis.

Authors:  Amalia Navarro-Martínez; Elena Navarro; Maria Jesús Castaño; Javier Solera
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.